Cite
HARVARD Citation
Zamek‐Gliszczynski, M. et al. (2018). ITC Commentary on Metformin Clinical Drug–Drug Interaction Study Design That Enables an Efficacy‐ and Safety‐Based Dose Adjustment Decision. Clinical pharmacology & therapeutics. 104 (5), pp. 781-784. [Online].